IgA nephropathy (IgAN) is the most common form of glomerulonephritis worldw
ide. It is characterized by recurrent gross hematuria, microhematuria and/o
r proteinuria and diffuse mesangial IgA deposits in glomeruli, It is predom
inantly a disease of young mates. Apart from primary IgAN (Berger's disease
), IgA deposits in the glomeruli are also seen in Henoch-Schonlein purpura
and in association with various of other diseases, particularly liver cirrh
osis. Originally it was thought that IgAN was a benign disease, but it is n
ow known that approximately 20-40% of patients develop progressive renal di
sease 5 to 25 years after diagnosis and progress to end-stage renal disease
. Clinical predictors of progressive disease are elevated serum creatinine
concentration at presentation, increased systemic blood pressure, persisten
t protein excretion > 1.0 g/day and histological predictors are glomerulosc
lerosis, tubular atrophy/interstitial fibrosis, extension of immune deposit
s to the perivascular space and crescent formation, Progression correlates
more closely with the severity of tubulointerstitial lesions than with the
degree of glomerular lesions. These features of IgAN reported in literature
were mostly, but not completely, confirmed by analysis of all consecutive
patients with biopsy proven IgAN and follow-up > 12 months in the renal uni
ts of Heidelberg and Prague using univariate analysis, multiple range test
and multiple regression analysis.